- Case Report
9 Citations
5,682 Views
5 Pages
Autoimmune Encephalitis and CSF Anti-GluR3 Antibodies in an MS Patient after Alemtuzumab Treatment
- Maria Chiara Buscarinu,
- Arianna Fornasiero,
- Giulia Pellicciari,
- Roberta Reniè,
- Anna Chiara Landi,
- Alessandro Bozzao,
- Cristina Cappelletti,
- Pia Bernasconi,
- Giovanni Ristori and
- Marco Salvetti
A 45-year-old Italian woman, affected by relapsing–remitting multiple sclerosis (RR-MS) starting from 2011, started treatment with alemtuzumab in July 2016. Nine months after the second infusion, she had an immune thrombocytopenic purpura (ITP)...